title: Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women.
abstract: BACKGROUND
  Despite CDC recommendations regarding universal catch-up vaccination against human papillomavirus (HPV), only about ten percent of young adult women in the United States have been vaccinated. The purpose of this study was to better understand reasons for non-vaccination among insured 19-26 year-old women and to evaluate future vaccination intentions.
  
  
  METHODS
  We used an administrative claims database from a large US managed care plan to identify women aged 19-26 for receipt of a mailed survey. From a sample of 1,375 women with no evidence of HPV vaccination from June 1, 2006 through April 30, 2007, 222 completed surveys were received, of which 185 were eligible for this analysis. The main outcome measures were unvaccinated women's attitudes and vaccine awareness, likelihood of future action regarding the vaccine, and reasons for inaction.
  
  
  RESULTS
  Among the 185 non-vaccinees, 25.4% were married, 83.2% were white, and 89.2% had a college or higher level education. The vaccine was described as very important by 32.4% of subjects, and 30.1% had discussed the vaccine with a doctor and received a doctor's recommendation. Half or fewer of respondents were "very" or "extremely" likely to discuss the vaccine with their doctor (50.0%), do additional research on the vaccine (42.6%), ask a doctor to get the vaccine (37.5%), or make an appointment to get the vaccine (27.8%), while 48.0% were "somewhat", "very", or "extremely" likely to do nothing to get the vaccine. Among the latter, reasons for taking no action included being married or in a monogamous relationship (54.9%), belief that the vaccine is too new (35.4%), not having enough information about the vaccine (31.7%), concerns about side effects (24.4%), and uncertainty about insurance coverage (24.4%).
  
  
  CONCLUSIONS
  Educational interventions may be needed to enhance HPV vaccination rates among 19-26 year-old women, particularly regarding information about vaccine safety, vaccine efficacy, insurance coverage, and the value of vaccination to women in monogamous relationships.
authors.affiliation: Department of Pediatrics, Indiana University School of Medicine, 410 W, 10th Street, HS 1001, Indianapolis, IN 46202, USA. gzimet@iupui.edu
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Zimet
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Weiss
authors.forename: Susan L
authors.initials: SL
authors.lastname: Rosenthal
authors.forename: Margaret B
authors.initials: MB
authors.lastname: Good
authors.forename: Michelle D
authors.initials: MD
authors.lastname: Vichnin
mesh_terms: D000328:Adult; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D006801:Humans; D007345:Insurance Claim Review; D008329:Managed Care Programs / Q000706:statistics & numerical data; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000523:psychology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D011795:Surveys and Questionnaires; D016312:Treatment Refusal / Q000523:psychology*; D014481:United States; D014611:Vaccination / Q000523:psychology*; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines
references.citation: Int J STD AIDS. 2003 May;14(5):300-6
references.pmid: 12803935
references.citation: Curr Opin Obstet Gynecol. 2006 Feb;18 Suppl 1:s23-8
references.pmid: 16520681
references.citation: Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S11-7
references.pmid: 18649932
references.citation: Vaccine. 2009 May 26;27(25-26):3391-4
references.pmid: 19200838
references.citation: Prev Med. 2009 May;48(5):426-31
references.pmid: 19100762
references.citation: Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S4-7
references.pmid: 18760711
references.citation: BJOG. 2010 Jan;117(2):137-42
references.pmid: 20050177
references.citation: BMJ. 2008 May 10;336(7652):1056-8
references.pmid: 18436917
references.citation: BMC Public Health. 2008 Oct 23;8:368
references.pmid: 18947430
references.citation: Rev Obstet Gynecol. 2008 Summer;1(3):122-8
references.pmid: 19015763
references.citation: Prev Med. 2009 May;48(5):420-5
references.pmid: 19133288
references.citation: Aust N Z J Public Health. 2007 Jun;31(3):235-42
references.pmid: 17679241
references.citation: Obstet Gynecol. 2008 May;111(5):1103-10
references.pmid: 18448742
references.citation: Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10
references.pmid: 14982671
references.citation: MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
references.pmid: 17380109
references.citation: N Engl J Med. 2007 May 10;356(19):1928-43
references.pmid: 17494926
references.citation: Policy Brief UCLA Cent Health Policy Res. 2009 Feb;(PB2009-3):1-6
references.pmid: 19288623
references.citation: MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-9
references.pmid: 20508593
references.citation: Prev Med. 2007 Aug-Sep;45(2-3):107-14
references.pmid: 17628649
references.citation: Vaccine. 2011 Jan 29;29(5):890-5
references.pmid: 20056186
references.citation: J Womens Health (Larchmt). 2009 Oct;18(10):1679-86
references.pmid: 19785564
references.citation: Commun Dis Intell Q Rep. 2008 Mar;32(1):94-8
references.pmid: 18522312
references.citation: Mayo Clin Proc. 2008 Jun;83(6):701-6; quiz 706-7
references.pmid: 18533087
references.citation: Br J Soc Psychol. 2001 Dec;40(Pt 4):471-99
references.pmid: 11795063
references.citation: Sex Transm Dis. 2003 Oct;30(10):774-8
references.pmid: 14520177
references.citation: N Engl J Med. 2007 May 10;356(19):1915-27
references.pmid: 17494925